These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20838952)

  • 1. Ontogenetic serotoninergic lesioning alters histaminergic activity in rats in adulthood.
    Jośko J; Drab J; Jochem J; Nowak P; Szkilnik R; Korossy-Mruk E; Boroń D; Kostrzewa RM; Brus H; Brus R
    Neurotox Res; 2011 Aug; 20(2):103-8. PubMed ID: 20838952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histaminergic activity in a rodent model of Parkinson's disease.
    Nowak P; Noras L; Jochem J; Szkilnik R; Brus H; Körossy E; Drab J; Kostrzewa RM; Brus R
    Neurotox Res; 2009 Apr; 15(3):246-51. PubMed ID: 19384597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioperamide, an H₃ receptor antagonist prevents [³H]glucose uptake in brain of adult rats lesioned as neonates with 5,7-dihydroxytryptamine.
    Jośko J; Drab J; Nowak P; Szkilnik R; Körossy E; Boroń D; Brus H; Kostrzewa RM; Brus R
    Neurotox Res; 2011 Jul; 20(1):93-6. PubMed ID: 20838953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels.
    Nowak P; Dabrowska J; Bortel A; Biedka I; Szczerbak G; Słomian G; Kostrzewa RM; Brus R
    Eur J Pharmacol; 2006 Dec; 552(1-3):46-54. PubMed ID: 17055481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.
    Brus R; Kostrzewa RM; Perry KW; Fuller RW
    J Pharmacol Exp Ther; 1994 Jan; 268(1):231-7. PubMed ID: 8301563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists.
    Nowak P; Nitka D; Kwieciński A; Jośko J; Drab J; Pojda-Wilczek D; Kasperski J; Kostrzewa RM; Brus R
    Pharmacol Rep; 2009; 61(2):311-8. PubMed ID: 19443944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogenetic noradrenergic lesion alters histaminergic activity in adult rats.
    Nowak P; Jochem J; Zwirska-Korczala K; Josko J; Noras L; Kostrzewa RM; Brus R
    Neurotox Res; 2008 Apr; 13(2):79-83. PubMed ID: 18515210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Bishop C; Walker PD
    Neuroscience; 2003; 121(3):649-57. PubMed ID: 14568025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive modulation by dopamine and serotonin neurons of receptor sensitivity of the alternate neurochemical system.
    Kostrzewa RM; Brus R; Perry KW
    Pol J Pharmacol; 1999; 51(1):39-47. PubMed ID: 10389143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed animal model of attention deficit hyperactivity disorder.
    Kostrzewa RM; Brus R; Kalbfleisch JH; Perry KW; Fuller RW
    Brain Res Bull; 1994; 34(2):161-7. PubMed ID: 7913871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson's Disease.
    Kostrzewa JP; Kostrzewa RM
    Neurotox Res; 2020 Mar; 37(3):543-552. PubMed ID: 31939043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.
    Nowak P; Bortel A; Dabrowska J; Biedka I; Slomian G; Roczniak W; Kostrzewa RM; Brus R
    Neurotox Res; 2008; 13(3-4):231-40. PubMed ID: 18522902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment in Pain Perception in Adult Rats Lesioned as Neonates with 5.7-Dihydroxytryptamine.
    Muchacki R; Szkilnik R; Malinowska-Borowska J; Żelazko A; Lewkowicz Ł; Nowak PG
    Adv Clin Exp Med; 2015; 24(3):419-27. PubMed ID: 26467129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine.
    Fletcher PJ; Selhi ZF; Azampanah A; Sills TL
    Neuropsychopharmacology; 2001 Apr; 24(4):399-409. PubMed ID: 11182535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors.
    Karamanakos PN; Pappas P; Marselos M
    Behav Brain Res; 2004 Jan; 148(1-2):199-208. PubMed ID: 14684260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease.
    Brus R; Jochem J; Nowak P; Adwent M; Boroń D; Brus H; Kostrzewa RM
    Neurotox Res; 2012 Feb; 21(2):143-8. PubMed ID: 21822760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of different histamine receptor agonists and antagonists on apomorphine-induced licking behavior in rat.
    Farzin D; Attarzadeh M
    Eur J Pharmacol; 2000 Sep; 404(1-2):169-74. PubMed ID: 10980276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats.
    Plech A; Brus R; Kalbfleisch JH; Kostrzewa RM
    Psychopharmacology (Berl); 1995 Jun; 119(4):466-73. PubMed ID: 7480527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF-1 fails to modify agonist-induced oral activity in neonatal 6-OHDA-treated rats.
    Gong L; Kostrzewa RM; Kalbfleisch JH
    Peptides; 1993; 14(6):1159-64. PubMed ID: 7907787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.